CLASS II ONGOING Drug recall · Reported 14 May 2025 · FDA Enforcement Report
temper tamer, 1 US fl oz., Homeopathic Oral Spray recalled
Siddha Flower Essences is recalling temper tamer, 1 US fl oz., Homeopathic Oral Spray, distributed nationwide in the US. The recall was initiated on 28 Apr 2025 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0410-2025
- FDA event ID
- 96763
- Recalling firm
- Siddha Flower Essences, Oxnard, CA
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 28 Apr 2025
- FDA classified
- 6 May 2025
- Reported
- 14 May 2025
- Type
- Voluntary: Firm initiated
- Customers notified by
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- Reason category
- Manufacturing (CGMP) Deviations
Timeline
| 28 Apr 2025 | Recall initiated by company | |
| 6 May 2025 | Classified by FDA | +8 days |
| 14 May 2025 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
CGMP Deviations
Product as listed by the FDA
temper tamer, 1 US fl oz. (29.6 mL), Homeopathic Oral Spray, Manufactured by: Siddha Flower Essences, Oxnard, CA, 93030 NDC 69779-020-01.
Where it was distributed
US Nationwide.
Questions about this recall
Why was it recalled?
CGMP Deviations
Which lots are affected?
Lot# S22-26424D; Exp 9/27/2027
Where was it sold?
US Nationwide.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.